Egalet Corp (NASDAQ:EGLT)

0.639
Delayed Data
As of Apr 23
 +0.0084 / +1.33%
Today’s Change
0.55
Today|||52-Week Range
4.48
-36.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$34.5M

Company Description

Egalet Corp. engages in the development, manufacture, and commercialization of innovative treatments for pain and other conditions. The firm offers ARYMO, OXAYDO and SPRIX. Its products contain non-narcotic and abuse-deterrent opioid formulations. The company was founded by Jean-Francois B. Formela in August 2013 and is headquartered in Wayne, PA.

Contact Information

Egalet Corp.
600 Lee Road
Wayne Pennsylvania 19087
P:(610) 833-4200
Investor Relations:

Employees

Shareholders

Other institutional25.13%
Individual stakeholders16.96%
Mutual fund holders10.92%

Top Executives

Robert Samuel RadiePresident, Chief Executive Officer & Director
Mark StrobeckChief Operating Officer & Executive Vice President
Stanley J. MusialChief Financial Officer, Secretary & Executive VP
Karsten LindhardtChief Scientific Officer
Patrick Michael SheaChief Commercial Officer